Vildagliptin/metformin

Vildagliptin/Metformin is a combination medication used in the treatment of Type 2 diabetes. It contains two active ingredients, Vildagliptin and Metformin, which work together to control blood sugar levels in people with diabetes.

Overview[edit | edit source]

Vildagliptin is a Dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) which works by increasing the amount of insulin produced by the body and reducing the amount of glucose produced by the liver. Metformin is a Biguanide which works by decreasing glucose production in the liver and increasing the body's sensitivity to insulin.

Uses[edit | edit source]

Vildagliptin/Metformin is used in the treatment of Type 2 diabetes. It is used when diet and exercise alone does not provide adequate control of blood sugar levels. It may be used alone or in combination with other diabetes medications.

Side Effects[edit | edit source]

Common side effects of Vildagliptin/Metformin include nausea, diarrhea, and abdominal pain. Serious side effects may include lactic acidosis, pancreatitis, and heart failure.

Precautions[edit | edit source]

Before taking Vildagliptin/Metformin, tell your doctor if you have kidney disease, liver disease, or a history of heart disease. This medication should not be used during pregnancy or breastfeeding without the advice of a doctor.

Interactions[edit | edit source]

Vildagliptin/Metformin may interact with other medications, including other diabetes medications, blood pressure medications, and certain antibiotics. Always tell your doctor about any other medications you are taking.

Dosage[edit | edit source]

The dosage of Vildagliptin/Metformin will depend on the individual's condition and response to treatment. It is usually taken once or twice a day with meals.

See Also[edit | edit source]

Vildagliptin/metformin Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.